1. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial. Issue 16 (December 2015) Authors: Röllig, Christoph; Serve, Hubert; Hüttmann, Andreas; Noppeney, Richard; Müller-Tidow, Carsten; Krug, Utz; Baldus, Claudia D; Brandts, Christian H; Kunzmann, Volker; Einsele, Hermann; Krämer, Alwin; Schäfer-Eckart, Kerstin; Neubauer, Andreas; Burchert, Andreas; Giagounidis, Aristoteles; Krause, St... Journal: Lancet oncology Issue: Volume 16:Issue 16(2015) Page Start: 1691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Allele‐specific PCR is a powerful tool for the detection of the MYD88 L265P mutation in diffuse large B cell lymphoma and decalcified bone marrow samples. (30th March 2015) Authors: Staiger, Annette M.; Ott, M. Michaela; Parmentier, Stefani; Rosenwald, Andreas; Ott, German; Horn, Heike; Griese, Ernst‐Ulrich Journal: British journal of haematology Issue: Volume 171:Number 1(2015:Oct.) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations – a registry based analysis. Issue 6 (12th May 2021) Authors: Middeke, Jan M.; Teipel, Raphael; Röllig, Christoph; Stasik, Sebastian; Zebisch, Armin; Sill, Heinz; Kramer, Michael; Scholl, Sebastian; Hochhaus, Andreas; Jost, Edgar; Brümmendorf, Tim H.; Naumann, Ralph; Steffen, Björn; Serve, Hubert; Altmann, Heidi; Kunzmann, Volker; Einsele, Hermann; Parmenti... Journal: Leukemia & lymphoma Issue: Volume 62:Issue 6(2021) Page Start: 1432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure. (October 2019) Authors: Stratmann, Jan; van Kann, Elisabeth; Rummelt, Christoph; Koschade, Sebastian; Röllig, Christoph; Lübbert, Michael; Schaich, Markus; Parmentier, Stefani; Sebastian, Martin; Chromik, Joerg; Becker von Rose, Aaron; Ballo, Olivier; Steffen, Björn; Serve, Hubert; Brandts, Christian; Shaid, Shabnam Journal: Leukemia research Issue: Volume 85(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome. (13th October 2015) Authors: von Dalowski, Felix; Kramer, Michael; Wermke, Martin; Wehner, Rebekka; Röllig, Christoph; Alakel, Nael; Stölzel, Friedrich; Parmentier, Stefani; Sockel, Katja; Krech, Mathias; Schmitz, Marc; Platzbecker, Uwe; Schetelig, Johannes; Bornhäuser, Martin; von Bonin, Malte Journal: Stem cells Issue: Volume 34:Number 2(2016:Feb.) Page Start: 357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Mesenchymal Stromal Cells for Treatment of Acute Steroid‐Refractory Graft Versus Host Disease: Clinical Responses and Long‐Term Outcome. (13th October 2015) Authors: von Dalowski, Felix; Kramer, Michael; Wermke, Martin; Wehner, Rebekka; Röllig, Christoph; Alakel, Nael; Stölzel, Friedrich; Parmentier, Stefani; Sockel, Katja; Krech, Mathias; Schmitz, Marc; Platzbecker, Uwe; Schetelig, Johannes; Bornhäuser, Martin; von Bonin, Malte Journal: Stem cells Issue: Volume 34:Number 2(2016:Feb.) Page Start: 357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗